Spark Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-19,711
Closed -$924K – 355
2020
Q1
$924K Sell
19,711
-53,089
-73% -$3.4M 0.49% 63
2019
Q4
$5.31M Sell
72,800
-10,000
-12% -$607K 0.62% 27
2019
Q3
$4.32M Sell
82,800
-123,400
-60% -$6.56M 0.55% 55
2019
Q2
$10.3M Buy
206,200
+82,400
+67% +$4.01M 0.72% 28
2019
Q1
$6.44M Buy
+123,800
New +$5.7M 0.3% 100
2018
Q3
– Sell
-50,900
Closed -$2.53M – 783
2018
Q2
$2.53M Buy
+50,900
New +$2.46M 0.15% 199
2017
Q3
– Sell
-31,200
Closed -$408K – 851
2017
Q2
$408K Buy
+31,200
New +$411K 0.03% 535
2016
Q4
– Sell
-39,800
Closed -$650K – 936
2016
Q3
$650K Buy
39,800
+27,700
+229% +$500K 0.05% 432
2016
Q2
$150K Buy
+12,100
New +$151K 0.01% 663

Other funds holding MYOK

Spark Investment Management's MYOK Position: Q2 2020 in Review

Spark Investment Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 19,711 shares — an estimated $924K sold.

Spark Investment Management first reported a position in MYOK in Q2 2016 and held it in 9 quarters. The position peaked at $10.3M in Q2 2019. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

  • Spark Investment Management reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 19,711 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $924K.
  • Spark Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q2 2016 and held it in 9 quarters.
  • Spark Investment Management's MyoKardia, Inc. Common Stock position peaked at $10.3M in Q2 2019.
  • 235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.